A new study, published in Nature Medicine, highlights the efficacy of patritumab deruxtecan (HER3-DXd), an antibody HER3-directed-drug conjugate (ADC), in patients with hormone receptor-positive metastatic breast cancer who had....
Pancreatic cancer, which affects a growing number of patients, remains one of the most aggressive forms due to the ability of cancer cells to resist traditional treatments such as....